DLX1 and neuroblastoma: Taken altogether, it is evident that MYCN amplification exhibits a crucial regulatory role in neuroblastoma cells, and our findings provide additional mechanistic insights through the regulation of pivotal transcription factors such as BCL6, KLF4, DLX1, NRF2, and STAT5B, which confer altered gene expression programs.